AstraZeneca's (AZN) blockbuster cholesterol drug Crestor failed to beat Pfizer's (PFE) Lipitor...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca's (AZN) blockbuster cholesterol drug Crestor failed to beat Pfizer's (PFE) Lipitor in a head-to-head study. The result is likely to cap any benefits AZN might have gained from when Lipitor loses its patent in November and cheap generics hit the market. Shares -3.3% in London. (PR)